Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron (Q35293000)

7 August 2017

1 reference

title

Amyotrophic lateral sclerosis and primary lateral sclerosis: evidence-based diagnostic evaluation of the upper motor neuron (English)

1 reference

amyotrophic lateral sclerosis

7 August 2017

main subject

0 references

4

Hiroshi Mitsumoto

1 reference

7 August 2017

Stephen Chan

1

1 reference

7 August 2017

Petra Kaufmann

series ordinal

2

1 reference

7 August 2017

Dikoma C Shungu

series ordinal

3

1 reference

7 August 2017

publication date

1 May 2003

1 reference

Neuroimaging clinics of North America

7 August 2017

published in

1 reference

7 August 2017

volume

13

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

307-326

1 reference

The epidemiology of motor neuron diseases: a review of recent studies

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Excitotoxicity hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

The distribution of the permanent paralysis in the lower limb in poliomyelitis; a clinical and pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Preclinical and subclinical events in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Onset, natural history and outcome in idiopathic adult motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Neuropathology of sporadic amyotrophic lateral sclerosis of long duration

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

The central nervous system in motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Evaluation of the patient with nontraumatic headache: an evidence based approach

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Foramen magnum meningioma presenting as amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Progressive dysphagia due to adult Chiari I malformation mimicking amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Bulbar-onset amyotrophic lateral sclerosis in a patient with Chiari I malformation

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Dural arteriovenous fistula of the spinal cord: an uncommon cause of myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Cervical spondylotic myopathy and Kennedy syndrome mimicking amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Location of the corticospinal tract in the internal capsule at MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

MRI-FLAIR images of the head show corticospinal tract alterations in ALS patients more frequently than T2-, T1- and proton-density-weighted images

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Magnetic resonance findings in amyotrophic lateral sclerosis using a spin echo magnetization transfer sequence. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Diffusion tensor MRI assesses corticospinal tract damage in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

MRI and clinical features in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Degeneration of the pyramidal tracts in patients with amyotrophic lateral sclerosis. A premortem and postmortem magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

The corticospinal tract in amyotrophic lateral sclerosis: an MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Brain and spinal cord MRI in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

MR imaging in the diagnosis of intramedullary spinal cord diseases that involve specific neural pathways or vascular territories

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Low intensity areas observed on T2-weighted magnetic resonance imaging of the cerebral cortex in various neurological diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

T2 shortening in the motor cortex: effect of aging and cerebrovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

A decrease in cerebral cortex intensity on T2-weighted with ageing images of normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Clinical significance of hypointensity in the motor cortex on T2-weighted images

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Frontal lobe atrophy in motor neuron diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Involvement of corpus callosum in amyotrophic lateral sclerosis shown by MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Corpus callosum atrophy in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Reduced MTR in the corticospinal tract and normal T2 in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Biological markers in the diagnosis and treatment of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Amyotrophic lateral sclerosis: the search for a spectroscopic marker of upper motoneuron involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis)

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

1H spectroscopy in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Effect of creatine supplementation on metabolite levels in ALS motor cortices

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

MRI and SPECT findings in amyotrophic lateral sclerosis. Demonstration of upper motor neurone involvement by clinical neuroimaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Single-photon emission computed tomographic investigation of patients with motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

N-isopropyl-p-123I-amphetamine single photon emission computer tomography in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Primary lateral sclerosis: a neuropsychological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Lowered cerebral glucose utilization in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: a comparative PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Cerebral atrophy in motor neuron disease evaluated by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Involvement of the frontotemporal lobe and limbic system in amyotrophic lateral sclerosis: as assessed by serial computed tomography and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

Imaging and neurochemical markers for diagnosis and disease progression in ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2803%2900018-2

7 January 2021

10.1016/S1052-5149(03)00018-2

Identifiers

DOI

1 reference

7 August 2017

1 reference